Here's an article on RATs that shows some of the problems Ellume has encountered since shipping their product to the US.
Towards the end it discusses the amount of money the US intends to spend on RATS.
As we know Australia has also been a bit slow in responding to RATs but that is now changing.
Ellume won a $300m contract/investment from the US Govt, but its product still isn't approved for Australia yet.
There's definitely opportunity if the RNO products work & they can execute on strategy.
https://www.theage.com.au/business/companies/australian-company-ellume-recalls-2-2m-covid-tests-in-us-over-false-positive-concerns-20211111-p597xt.html
- Forums
- ASX - By Stock
- RNO
- Ann: Rhinoswab clinical trial approved at St Vincent's Hospital
Ann: Rhinoswab clinical trial approved at St Vincent's Hospital, page-28
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla